Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Abbisko Cayman Ltd

2256
Current price
4.45 HKD 0 HKD (0.00%)
Last closed 4.45 HKD
ISIN KYG0028A1085
Sector Healthcare
Industry Biotechnology
Exchange Hong Kong Stock Exchange
Capitalization 3 079 772 731 HKD
Yield for 12 month +22.93 %
1Y
3Y
5Y
10Y
15Y
2256
21.11.2021 - 28.11.2021

Abbisko Cayman Limited, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule oncology therapies in Mainland China. The company's product candidates are primarily small molecules that focus on small molecule precision oncology and small molecule immuno-oncology therapeutic areas. It is also involved in the research and development in areas of biomedical and biotechnology; and provision of technical and technical consultation services. Abbisko Cayman Limited has co-discovery collaboration agreement with Eli Lilly and Company for the discovery, development, and commercialization of novel molecules; and BeiGene, Ltd. on the combination therapy of fexagratinib and tislelizumab, an anti-PD-1 antibody for treating urothelial cancer with FGFR2/3 genetic alterations. The company was founded in 2016 and is headquartered in Shanghai, the People's Republic of China. Address: Building 3, Shanghai, China

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

88.58 HKD

P/E ratio

Dividend Yield

Current Year

+19 081 522 HKD

Last Year

Current Quarter

+19 081 522 HKD

Last Quarter

Current Year

+19 081 522 HKD

Last Year

Current Quarter

+19 081 522 HKD

Last Quarter

Key Figures 2256

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -30 387 272 HKD
Operating Margin TTM 48.65 %
PE Ratio
Return On Assets TTM -1.03 %
PEG Ratio
Return On Equity TTM -0.74 %
Wall Street Target Price 88.58 HKD
Revenue TTM 497 834 508 HKD
Book Value 3.35 HKD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 2509 %
Dividend Yield
Gross Profit TTM 22 707 612 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin -3.26 %

Dividend Analytics 2256

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 2256

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 2256

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.5022
Price Sales TTM 6.1109
Enterprise Value EBITDA 8.9038
Price Book MRQ 1.328

Financials 2256

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 2256

For 52 weeks

2.05 HKD 5.4 HKD
50 Day MA 3.59 HKD
Shares Short Prior Month
200 Day MA 3.11 HKD
Short Ratio
Shares Short
Short Percent